Search Results

OVER Trial Analysis Evaluates Predictors and Outcomes of Endoleaks in EVAR

December 2, 2015—In the Journal of Vascular Surgery (JVS), Brajesh K. Lal, MD, et al published an analysis that identifies characteristics, risk factors, and long-term outcome of endoleaks in patients treated with endovascular aneurysm repair (EVAR) in the Veterans Affairs Open Versus Endovascular Repair (OVER) trial of abdominal aortic aneurysms (2015;62:1394–1404). The randomized controlled OVER trial compared open repair and EVAR in standard-risk patients with infrarenal aortic aneurysms. 

American Venous Forum to Collaborate With NIH's C-TRACT Trial

November 14, 2019—In a letter to American Venous Forum (AVF) members, AVF President Brajesh K. Lal, MD, announced that the AVF and the National Institutes of Health–funded C-TRACT trial have entered into a partnership in which the AVF will contribute its expertise, perspective, and work effort to advance the trial’s success.

CREST Analysis Demonstrates Equally Low Restenosis Rates for CAS and CEA

February 1, 2012—At the American Stroke Association's (ASA) International Stroke Conference in New Orleans, Louisiana, Brajesh K. Lal, MD, presented 2-year findings on restenosis rates from an analysis of the CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial) study.

SVS Issues Clinical Competence Statement on Training and Credentialing for TCAR

June 22, 2020—The Society for Vascular Surgery (SVS) announced the publication of a clinical competence statement on training and credentialing for transcarotid artery revascularization (TCAR) by Brajesh K. Lal, MD, et al online ahead of print in Journal of Vascular Surgery.

CREST-2 Completes Enrollment

August 13, 2024—CREST-2, the Carotid Revascularization Endarterectomy or Stenting Trial, has completed patient enrollment.

CRISP Consortium Study Evaluates Elucid Bio’s vascuCAP AI Software to Predict Stroke

July 1, 2020—Elucid Bio, manufacturer of the vascuCAP software, announced that its artificial intelligence (AI) technology demonstrated > 70% improvement in the accuracy of stroke prediction compared with a stenosis-based approach to risk-stratification during a 6-year period in the CRISP Consortium study of carotid risk prediction.

American Venous Forum to Launch American Venous Registry

November 15, 2010—The American Venous Forum (AVF) announced that it will launch the American Venous Registry (AVR) at its 23rd annual meeting to be held in San Diego, California, on February 23 through 26, 2011.

American Venous Forum to Launch American Venous Registry

November 15, 2010—The American Venous Forum (AVF) announced that it will launch the American Venous Registry (AVR) at its 23rd annual meeting to be held in San Diego, California, on February 23 through 26, 2011.

Venous Patient Outcome Registry Launched by Heart and Vascular Outcomes Research Institute

November 1, 2013—The Heart and Vascular Outcomes Research Institute (HVORI, Beverly, MA) announced the launch of the Venous Patient Outcome Registry, which is designed to assess clinical outcomes for various treatments of deep and superficial venous diseases.

American Venous Registry Launches IVC Filter Module

June 16, 2011—The American Venous Forum (AVF) announced the launch of the Inferior Vena Cava (IVC) Filter Module for its American Venous Registry (AVR).

Study Indicates Cognitive Impairment in Otherwise Asymptomatic Carotid Stenosis Patients

October 4, 2017—The Society for Vascular Surgery (SVS) announced the publication of a study showing that approximately half of asymptomatic carotid stenosis patients had mild to moderate cognitive impairment.